This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/mesh/concept/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02071/identifier/chemspider/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02071/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n15http://linked.opendata.cz/ontology/mesh/
n5http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02071/identifier/pubchem-compound/
n6http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02071/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02071/identifier/drugbank/

Statements

Subject Item
n2:DB02071
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB02071 n11:DB02071
dcterms:title
WAY-151693
adms:identifier
n4:4215 n10:4368 n12:46508910 n13:DB02071 n14:WAY
n5:synonym
n-hydroxy-2-[(4-methoxy-benzenesulfonyl)-pyridin-3-ylmethyl-amino]-3-methyl-benzamide
n15:hasConcept
n16:M0371199
n5:IUPAC-Name
n6:271B61E1-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B61E7-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B61E6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B61E3-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B61E4-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B61E5-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B61DF-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B61DD-363D-11E5-9242-09173F13E4C5 n6:271B61E0-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B61DE-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B61ED-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B61EE-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B61E8-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B61E9-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B61EB-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B61EA-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B61EC-363D-11E5-9242-09173F13E4C5
n5:affectedOrganism
Humans and other mammals
n5:Bioavailability
n6:271B61F3-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B61F5-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B61F6-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B61F2-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B61F1-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B61F4-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B61E2-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B61EF-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B61F0-363D-11E5-9242-09173F13E4C5